MedTrace Logo

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

NCT06220526 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2026-05-01

No results posted yet for this study

Summary

This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.

Conditions

  • Suspected Sarcoidosis

Interventions

DEVICE

endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)

Transbronchial biopsy with Menghini-type or Franseen type Needle

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Kazuhiro Yasufuku · UHN

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-18
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220526 on ClinicalTrials.gov